New York, NYNCT06569082Now EnrollingIRB Ready

Graft Failure Clinical Trial in New York, NY

Access cutting-edge graft failure treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by NYU Langone Health

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access graft failure specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related graft failure treatment provided free

Apply for This New York Location

Check if you qualify for this graft failure clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Graft Failure Study in New York

The proposed trial is a single arm, non-randomized, single center pilot study utilizing CliniMACS CD34 Reagent System for patients following allogeneic hematopoietic stem cell transplant (HSCT) requiring treatment of graft dysfunction or failure.

Sponsor: NYU Langone Health

Who Can Participate

Inclusion Criteria

Recipient of allogeneic transplantation, adult ≥18 years, from any type of donor including matched related, matched unrelated, mismatched related or mismatched unrelated or haploidentical donor transplant.
Documented evidence of graft dysfunction or failure (a-c):
Primary graft Failure: Graft failure is defined as failure to achieve neutrophil engraftment by day +28 or lack of donor chimerism \> 50% by day 45 not due to the underlying malignancy;
Poor graft function is defined by at least 2 of the following 3 criteria: Hemoglobin \< 8 g/dL, ANC \< 0.5x109/L, and platelets \< 20x109/L. The cytopenia must be unexplained (such as by disease relapse) and unresponsive to hematopoietic growth factors and must last at least 4 weeks;
Secondary graft failure is defined as poor graft function associated with donor chimerism \< 5% after initial engraftment
Transplanted donor availability
Negative pregnancy test within seven (7) days of product infusion for women of childbearing potential.

Exclusion Criteria

Graft failure due to disease relapse or evidence of disease relapse or progression
Donor unavailable or unable to collect peripheral HPC by apheresis
Responsive to conventional measures (such as, hematopoietic growth factor)
Allergic reaction to murine proteins or iron dextran
Women of childbearing potential with positive serum HCG

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06569082) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Graft Failure Treatment Options in New York, NY

If you're searching for graft failure treatment options in New York, NY, this clinical trial (NCT06569082) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all graft failure clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in New York, NY

See all atrial fibrillation clinical trials recruiting in New York — not just this study.

Browse Atrial Fibrillation Trials in New York →

Browse More Trials by Condition

Atrial Fibrillation TrialsRheumatoid Arthritis TrialsFanconi Anemia TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY